company background image
A118

Wooridul Huebrain KOSE:A118000 Stock Report

Last Price

₩1.16k

Market Cap

₩97.8b

7D

2.2%

1Y

-40.3%

Updated

23 May, 2022

Data

Company Financials
A118000 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance1/6
Financial Health4/6
Dividends0/6

A118000 Stock Overview

Wooridul Huebrain Limited engages in the medical, life and health, pharmaceutical, and storage businesses.

Wooridul Huebrain Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Wooridul Huebrain
Historical stock prices
Current Share Price₩1,155.00
52 Week High₩2,325.00
52 Week Low₩1,065.00
Beta1.74
1 Month Change-12.50%
3 Month Change-13.81%
1 Year Change-40.31%
3 Year Change-49.56%
5 Year Change-63.39%
Change since IPO-87.71%

Recent News & Updates

Mar 22
There Are Some Holes In Wooridul Huebrain's (KRX:118000) Solid Earnings Release

There Are Some Holes In Wooridul Huebrain's (KRX:118000) Solid Earnings Release

Following the release of a positive earnings report recently, Wooridul Huebrain Limited's ( KRX:118000 ) stock...

Shareholder Returns

A118000KR HealthcareKR Market
7D2.2%7.5%1.6%
1Y-40.3%-39.9%-14.2%

Return vs Industry: A118000 matched the KR Healthcare industry which returned -39.9% over the past year.

Return vs Market: A118000 underperformed the KR Market which returned -14.2% over the past year.

Price Volatility

Is A118000's price volatile compared to industry and market?
A118000 volatility
A118000 Average Weekly Movement4.5%
Healthcare Industry Average Movement5.8%
Market Average Movement5.5%
10% most volatile stocks in KR Market10.4%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A118000 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: A118000's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200932Soo-Kyung Kimhttps://www.wooridulls.co.kr

Wooridul Huebrain Limited engages in the medical, life and health, pharmaceutical, and storage businesses. It sells medical equipment and appliances, health equipment, medicines, and computer servers. Wooridul Huebrain Limited was formerly known as Wooridul Life Sciences Limited and changed its name to Wooridul Huebrain Limited in April 2014.

Wooridul Huebrain Fundamentals Summary

How do Wooridul Huebrain's earnings and revenue compare to its market cap?
A118000 fundamental statistics
Market Cap₩97.83b
Earnings (TTM)₩9.82b
Revenue (TTM)₩18.61b

10.0x

P/E Ratio

5.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A118000 income statement (TTM)
Revenue₩18.61b
Cost of Revenue₩13.55b
Gross Profit₩5.06b
Other Expenses-₩4.75b
Earnings₩9.82b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)115.89
Gross Margin27.20%
Net Profit Margin52.74%
Debt/Equity Ratio24.8%

How did A118000 perform over the long term?

See historical performance and comparison

Valuation

Is Wooridul Huebrain undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


9.97x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate A118000's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate A118000's fair value for valuation analysis.


Price To Earnings Ratio

PE vs Industry: A118000 is good value based on its PE Ratio (10x) compared to the Asian Healthcare industry average (17.4x).

PE vs Market: A118000 is good value based on its PE Ratio (10x) compared to the KR market (14x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate A118000's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: A118000 is good value based on its PB Ratio (0.8x) compared to the KR Healthcare industry average (2.3x).


Future Growth

How is Wooridul Huebrain forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.6%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Wooridul Huebrain has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Wooridul Huebrain performed over the past 5 years?

Past Performance Score

1/6

Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


56.5%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: A118000 has a large one-off gain of ₩10.1B impacting its December 31 2021 financial results.

Growing Profit Margin: A118000's current net profit margins (52.7%) are lower than last year .


Past Earnings Growth Analysis

Earnings Trend: A118000 has become profitable over the past 5 years, growing earnings by 56.5% per year.

Accelerating Growth: A118000's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: A118000 had negative earnings growth (-21%) over the past year, making it difficult to compare to the Healthcare industry average (33.2%).


Return on Equity

High ROE: A118000's Return on Equity (8.3%) is considered low.


Financial Health

How is Wooridul Huebrain's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: A118000's short term assets (₩80.4B) exceed its short term liabilities (₩53.3B).

Long Term Liabilities: A118000's short term assets (₩80.4B) exceed its long term liabilities (₩3.6B).


Debt to Equity History and Analysis

Debt Level: A118000 has more cash than its total debt.

Reducing Debt: A118000's debt to equity ratio has reduced from 64.8% to 24.8% over the past 5 years.

Debt Coverage: A118000's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if A118000's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is Wooridul Huebrain current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate A118000's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A118000's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if A118000's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A118000's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A118000 has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Soo-Kyung Kim (72 yo)

no data

Tenure

Ms. Soo-Kyung Kim served as Chief Executive officer of Wooridul Pharmaceutical Limited (formerly known as Wooridul Life Sciences Ltd). Ms. Soo-Kyung Kim served as Co-Chief Executive Officer of Sudo Pharmac...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 68.1%.


Top Shareholders

Company Information

Wooridul Huebrain Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Wooridul Huebrain Limited
  • Ticker: A118000
  • Exchange: KOSE
  • Founded: 2009
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: ₩97.832b
  • Shares outstanding: 84.70m
  • Website: https://www.wooridulls.co.kr

Number of Employees


Location

  • Wooridul Huebrain Limited
  • 156, No. 202, Dream Building)
  • Jinandong
  • Hwaseong-si
  • Gyeonggi-do
  • South Korea

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/23 00:00
End of Day Share Price2022/05/23 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.